Inventor · disambiguated record
Kevin S. Currie
Also filed as: CURRIE KEVIN · CURRIE KEVIN S
72 granted patents·26 pending applications·1,437 citations·filing 1999–2024
99Inventor score
Files withGILEAD SCIENCES INC36GILEAD CONNECTICUT INC15NEUROGEN CORP13CGI PHARMACEUTICALS INC9CURRIE KEVIN S8
Top patents by PatentIndex Score
98 records- 0198US8450321B26-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitorMITCHELL SCOTT A·Filed 2012·Granted May 28, 2013·159 cites·2 claims
- 0297US9290505B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Mar 22, 2016·23 cites·36 claims
- 0397US9120811B26-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphomaGILEAD CONNECTICUT INC·Filed 2014·Granted Sep 1, 2015·28 cites·10 claims
- 0497US8765761B26-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitorGILEAD CONNECTICUT INC·Filed 2013·Granted Jul 1, 2014·29 cites·7 claims
- 0597US7838523B2Certain substituted amides, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2007·Granted Nov 23, 2010·28 cites·72 claims
- 0696US8748607B2Imidazopyrizine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Jun 10, 2014·34 cites·13 claims
- 0796US8455493B2Imidazopyrazine Syk inhibitorsMITCHELL SCOTT A·Filed 2009·Granted Jun 4, 2013·55 cites·10 claims
- 0896US8440667B2Imidazopyrazine Syk inhibitorsMITCHELL SCOTT A·Filed 2009·Granted May 14, 2013·44 cites·9 claims
- 0996US7393848B2Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compoundsCGI PHARMACEUTICALS INC·Filed 2004·Granted Jul 1, 2008·67 cites·50 claims
- 1095US9796718B26-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD CONNECTICUT INC·Filed 2015·Granted Oct 24, 2017·14 cites·2 claims
- 1195US9567348B2Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2015·Granted Feb 14, 2017·15 cites·2 claims
- 1295US9504684B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·18 cites·30 claims
- 1395US9212191B26-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitorGILEAD CONNECTICUT INC·Filed 2014·Granted Dec 15, 2015·19 cites·7 claims
- 1495US7160885B2Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activityCGI PHARMACEUTICALS INC·Filed 2004·Granted Jan 9, 2007·77 cites·41 claims
- 1594US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 1694US8962835B2Imidazopyrazine Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Feb 24, 2015·22 cites·8 claims
- 1794US7884108B2Certain substituted pyrazinonesCGI PHARMACEUTICALS INC·Filed 2008·Granted Feb 8, 2011·35 cites·44 claims
- 1894US6559163B22,4-substituted quinoline derivativesNEUROGEN CORP·Filed 2001·Granted May 6, 2003·61 cites·31 claims
- 1993US7405295B2Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compoundsCGI PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·98 cites·59 claims
- 2092US7947835B2Certain substituted amides, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2006·Granted May 24, 2011·27 cites·67 claims
- 2192US7642267B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2007·Granted Jan 5, 2010·20 cites·21 claims
- 2292US7189723B2Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activityCGI PHARMACEUTICALS INC·Filed 2004·Granted Mar 13, 2007·48 cites·35 claims
- 2392US6414147B12-amino-9-alkylpurines: GABA brain receptor ligandsNEUROGEN CORP·Filed 1999·Granted Jul 2, 2002·60 cites·110 claims
- 2491US10842803B2Imidazopyridines Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Nov 24, 2020·3 cites·11 claims
- 2591US9968601B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted May 15, 2018·7 cites·53 claims
- 2691US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 2791US7312341B26-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2003·Granted Dec 25, 2007·50 cites·82 claims
- 2891US6949562B2Heterocyclic compounds as ligands of the GABAA receptorPFIZER·Filed 2003·Granted Sep 27, 2005·54 cites·34 claims
- 2991US6653471B2Heterocyclic compounds as ligands of the GABAA receptorNEUROGEN CORP·Filed 2001·Granted Nov 25, 2003·54 cites·27 claims
- 3091US6413956B1Substituted 4-oxo-quinoline-3-carboxamidesNEUROGEN CORP·Filed 2000·Granted Jul 2, 2002·62 cites·64 claims
- 3190US11739065B2FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2021·Granted Aug 29, 2023·1 cites·17 claims
- 3290US10342794B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2018·Granted Jul 9, 2019·5 cites·15 claims
- 3390US8618107B2Pyridone and aza-pyridone compounds and methods of useBARBOSA ANTONIO J M·Filed 2011·Granted Dec 31, 2013·24 cites·30 claims
- 3490US8058446B2Certain substituted amides, method of making, and method of use thereofBLOMGREN PETER A·Filed 2007·Granted Nov 15, 2011·19 cites·32 claims
- 3589US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 3689US10421730B2FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2017·Granted Sep 24, 2019·3 cites·15 claims
- 3789US10093684B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Granted Oct 9, 2018·5 cites·10 claims
- 3889US9938278B2FXR (NR1H4) modulating compoundsGILEAD SCIENCES INC·Filed 2015·Granted Apr 10, 2018·9 cites·12 claims
- 3989US9562056B2Imidazopyridines Syk inhibitorsBLOMGREN PETER A·Filed 2011·Granted Feb 7, 2017·11 cites·7 claims
- 4089US6919340B2Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereofCELLULAR GENOMICS INC·Filed 2003·Granted Jul 19, 2005·54 cites·34 claims
- 4188US10092583B2Imidazopyridines Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Oct 9, 2018·5 cites·19 claims
- 4287US11517570B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineKRONOS BIO INC·Filed 2020·Granted Dec 6, 2022·1 cites·22 claims
- 4387US10828299B2Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD SCIENCES INC·Filed 2019·Granted Nov 10, 2020·3 cites·18 claims
- 4484US12263163B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 4583US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 4683US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 4783US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 4883US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 4983US9931338B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Apr 3, 2018·3 cites·20 claims
- 5081US8426424B2Certain substituted amides, method of making, and method of use thereofBLOMGREN PETER A·Filed 2009·Granted Apr 23, 2013·5 cites·30 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →